Company: PCRX
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001396814-25-000089
Chunk: 1

Company: Pacira BioSciences, Inc.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 5.07
Chunk 1
---
Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 10, 2025, the Company held the Annual Meeting in Parsippany, New Jersey and via live webcast online at www. cesonlineservices. com/pcrx25_vm. As of April 17, 2025, the record date for the Annual Meeting, 46,290,830 shares of the Company’s common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted on at the Annual Meeting is as follows:

Proposal 1 - Election of three Class II directors to hold office until the 2028 annual meeting of stockholders, and until their respective successors have been duly elected and qualified.

  Nominee:                  For       Withhold      Broker Non-Votes  
 ──────────────────────────────────────────────────────────────────────
  Marcelo Bigal      33,364,221      4,017,587             8,909,022  
  Frank D. Lee       32,858,858      4,522,950             8,909,022  
  Alethia Young      28,757,450      8,624,358             8,909,022  

Proposal 2 - Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.

         For      Against      Abstain  
 ────────────────────────────────────────
  40,022,569      352,947       20,917  

Proposal 3 - Advisory vote to approve the compensation of the Company’s named executive officers.

         For         Against      Abstain      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────────
  14,752,829      22,595,202       33,777             8,909,022  

Proposal 4 - Advisory vote to approve the frequency of future advisory votes to approve the compensation of the Company’s named executive officers.

    One Year      Two Years      Three Years      Abstain      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────────────────────────
  35,312,982         10,044        2,038,514       20,268             8,909,022  

Based on these results and good corporate governance, the Company’s board of directors (the